Autori: Pemmaraju Naveen
| Naslov | TRANSFORM-1 phase 3 study: efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis (Article) |
| Autori | Pemmaraju Naveen ... Bogdanovic Andrija ... (broj koautora 29) |
| Info | BLOOD, (2026), vol. 148 br. 16, str. 2029-2042 |
| Projekat | AbbVie; US Department of Defense; National Cancer Institute, National Institutes of Health [P30CA016672]; MD Anderson Cancer Center Support Grant shared resources [P30CA016672] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis (Meeting Abstract) |
| Autori | Pemmaraju Naveen ... Bogdanovic Andrija D ... (broj koautora 24) |
| Info | BLOOD, (2023), vol. 142 br. , Suppl. 1, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
